Cvs Health (CVS) Receivables - Net (2009 - 2026)

Cvs Health's Receivables - Net history runs 18 years deep, the most recent figure standing at $41.0 billion for Q1 2026.

• Quarterly Receivables - Net rose 3.45% year-over-year to $41.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.0 billion (up 3.45% YoY) and the FY2025 annual result came in at $39.8 billion, up 9.08% from the prior year.
• Receivables - Net was $41.0 billion for Q1 2026 at Cvs Health, up from $39.8 billion in the prior quarter.
• Across five years, Receivables - Net topped out at $43.9 billion in Q3 2025 and bottomed at $4.7 billion in Q4 2024.
• A 5-year average of $32.0 billion and a median of $32.4 billion in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2022 — Receivables - Net soared 975.13% — and 2024, when it tumbled 86.57%.
• Cvs Health's Receivables - Net stood at $27.3 billion in 2022, then grew by 29.15% to $35.2 billion in 2023, then tumbled by 86.57% to $4.7 billion in 2024, then soared by 740.82% to $39.8 billion in 2025, then increased by 3.05% to $41.0 billion in 2026.
• Business Quant data shows CVS's Receivables - Net at $41.0 billion in Q1 2026, $39.8 billion in Q4 2025, and $43.9 billion in Q3 2025.